Cargando…
Retraction: Role of methyle blue in the management of mild, moderate and severe COVID-19 disease
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810929/ https://www.ncbi.nlm.nih.gov/pubmed/36618143 http://dx.doi.org/10.4103/2249-4863.359352 |
Ejemplares similares
-
Role of methyle blue in the management of mild, moderate and severe COVID-19 disease
por: Bawaskar, Himmatrao Saluba, et al.
Publicado: (2022) -
Retraction: Intracranial pressure waveform changes in
Alzheimer’s disease and mild cognitive impairment
por: Ribeiro, Estela Barbosa, et al.
Publicado: (2021) -
Neutrophil extracellular traps: Their role in periodontal disease: Retraction
Publicado: (2015) -
Retraction notice to: “Antiviral treatment could not provide clinical benefit in management of mild COVID-19: A Retrospective Experience from Field hospital” [Journal of Infection and Public Health14/9 (2021) 1206- 1211]
por: Aumpan, Natsuda, et al.
Publicado: (2022) -
Retraction: Role of miR-132/methyl-CpG-binding protein 2 in the regulation of neural stem cell differentiation
Publicado: (2020)